Research Roundup: Pediatric Brain Disease; Covid And Heart Attacks; MS
Each week, KFF Health News compiles a selection of health policy studies and briefs.
The independent source for health policy research, polling, and news.
4,141 - 4,160 of 112,886 Results
Each week, KFF Health News compiles a selection of health policy studies and briefs.
Editorial writers discuss these public health topics.
CIDRAP reports that if confirmed, they'd bring the state's total to five cases over the past few weeks. In other news from around the nation, a call to investigate youth residential treatment facilities, an investigation into whether school districts are undercounting students who are homeless, and more.
The clock is ticking down on the current extensions of pandemic-era rules that give telehealth providers the ability to prescribe medications. With no new government regulations yet to materialize, companies are operating in a vacuum of information. Other health industry news reports on insurance costs, biotech, and more.
This week, a phase 3 clinical trial showed aztreonam-avibactam might be treatment option for patients facing multidrug-resistant infections. Meanwhile, research shows that penicillin allergies in nursing homes residents contribute to over prescription of broad spectrum antibiotics, adding to antimicrobial resistance.
The FDA issued a warning in June to stop labeling products as containing sesame (a known allergen) when they did not. Bimbo Bakeries USA refused, claiming the labels prevent people from inadvertently eating foods that can trigger potentially life-threatening reactions.
Democratic presidential nominee Kamala Harris is trying to appeal to undecided voters with her major policy pitch to add home health aide coverage to Medicare. At his campaign stop Wednesday, Republican presidential nominee Donald Trump hurled insults at his rival as well as the hosts of "The View," where Harris unveiled her Medicare plan.
Meanwhile, as Florida braced for a direct hit from Hurricane Milton, home health care providers made sure patients had the medical supplies and other necessities required to weather the storm and the likely loss of power.
UNICEF says its findings underscore the need to strengthen laws and help children recognize and report sexual violence. Separately, A CDC report details the extent of childhood traumatic experiences. Also, the number of adults affected by suicide continues to rise, The Harris Poll finds.
After Hurricane Helene disrupted production of IV fluids at a factory in North Carolina, officials worked to protect the supply from a plant in Daytona Beach, Florida as Hurricane Milton moved through. Meanwhile, hospitals are scrambling to conserve fluids during the supply shortage.
Today's early morning highlights from the major news organizations.
Nearly 1 in 3 Americans — in the only wealthy country in the world to not have a developed universal health care system — lack reliable primary care access. Meanwhile, unlike JD Vance, Americans are getting shorter due in part to poor access to quality health care and nutrition.
Read recent commentaries about pharmaceutical issues.
Editorial writers tackle these public health issues.
A new study discovered that live virus replication was detectable in semen in a patient infected with Oropouche virus some 16 days after symptom onset, suggesting a risk of sexual transmission. Separately, tickborne babesiosis is on the rise.
Health insurance companies are expected to pull back slightly from Medicare Advantage investing in 2025. Instead, Modern Healthcare reports, they will focus on Dual-Eligible Special Needs Plans, or D-SNPs, which cover people who are eligible for both Medicare and Medicaid. Other industry news is on employer plans, executive jobs, and more.
In southwestern states that routinely see sweltering temperatures, the stimulant was found in a third of heat deaths in 2023. Also, the successes and setbacks of modern medicine.
Axios reports the Biden administration today will release a preliminary list of generic drugs for Medicare recipients that would cost no more than $2 out of pocket. The pilot program aims to test drug adherence and health outcomes.
Compounding pharmacies sued the FDA after its declaration, bringing an end to the sale of the "copycat" drugs they provide. Meanwhile, as demand soars for weight loss drugs, WeightWatchers eyes compound version of the drug for participants in its programs.
The Wall Street Journal reports that Danco, the pharmaceutical company that makes mifepristone under the label Mifeprex, plans to apply for FDA approval for use of the drug in managing miscarriages. If approved the drug could become more widely available, when its use is already under legal challenge as part of a medication abortion protocol.
© 2026 KFF